A N D O

Will My US Doctor Work With a Korean Hospital? Records, Continuity, and Follow-Up

Last updated: July 28, 2026 · The continuity question is the real objection behind 'doctors advise against medical tourism'. So here is the actual mechanism.

Direct answer: Yes, and not as a favor. You own your records (HIPAA right of access), Korean international clinics return English reports and DICOM originals, the protocols are the same evidence-based playbook, and your US physician stays quarterback before and after. The successful pattern in documented patient accounts is always the same: the local doctor was kept in the loop from the first written opinion, not surprised after the fact.

The coordination pattern, step by step

StepWhat movesWho does it
1 · Records outClinic notes, labs, imaging (DICOM), pathology report, slides/blocks on loan if neededYou request under HIPAA; a facilitator chases, digitizes, translates
2 · Written opinion backEnglish written second opinion from a Seoul tertiary center, 5–10 business days, ₩320,000 published feeKorean center; you hand it to your US oncologist
3 · The three-way conversationYour US doctor reviews the Korean read, agreement confirms your plan; divergence gives you a concrete question, with numbersYou + both physicians
4 · If you goTreatment in Seoul with interpreter escort; your US doctor receives updatesKorean international clinic
5 · Homecoming fileEnglish treatment summary, op notes, regimen with international drug names, DICOM originals, remote check-in scheduleReturns with you. Surveillance at home starts from a baseline, not from zero

Why the "doctors advise against it" narrative doesn't quite apply

Honest caveats

Some US physicians will still be skeptical. The productive move is bringing them the written opinion and the DICOM baseline, not asking for permission in the abstract.

Complication care at home bills at US prices and travel-medical policies rarely cover pre-existing conditions. Plan the follow-up map before flying, not after.

Active-treatment handoffs (mid-chemo) are genuinely hard and usually inadvisable; the clean entry points are diagnosis, surgery planning, and surveillance.

Related guides

Can't afford US treatment? Every option · Is treatment in Korea safe? · How the $230 second opinion works